Ryan E. Looper, Ph.D.
Affiliations: | 2004 | Colorado State University, Fort Collins, CO |
Google:
"Ryan Looper"Mean distance: 8.84 | S | N | B | C | P |
Parents
Sign in to add mentor| James Robert Vyvyan | grad student | Western Washington University | ||
| Robert Michael Williams | grad student | 2004 | Colorado State | |
| (Concise asymmetric syntheses of the cylindrospermopsin alkaloids.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rawson KB, Neuberger T, Smith TB, et al. (2023) comparison of V.A.C.® Granufoam Silver™ and V.A.C.® Granufoam™ loaded with a first-in-class bis-dialkylnorspermidine-terphenyl antibiofilm agent. Biofilm. 6: 100142 |
| Rawson KB, Neuberger T, Smith T, et al. (2022) Antibiofilm potential of a negative pressure wound therapy foam loaded with a first-in-class tri-alkyl norspermidine-biaryl antibiotic. Journal of Biomedical Materials Research. Part B, Applied Biomaterials |
| Williams DL, Kawaguchi B, Taylor NB, et al. (2020) efficacy of a unique first-in-class antibiofilm antibiotic for biofilm-related wound infections caused by . Biofilm. 2: 100032 |
| Miller M, Rogers JC, Badham MA, et al. (2020) Examination of a first-in-class bis-dialkylnorspermidine-terphenyl antibiotic in topical formulation against mono and polymicrobial biofilms. Plos One. 15: e0234832 |
| Looper RE, Serrano CM, Kannareddy HR, et al. (2020) Unifying the aminohexopyranose- and peptidyl-nucleoside antibiotcs; implications for antibiotic design. Angewandte Chemie (International Ed. in English) |
| Williams DL, Smith SR, Peterson BR, et al. (2019) Growth substrate may influence biofilm susceptibility to antibiotics. Plos One. 14: e0206774 |
| Ashton NN, Allyn G, Porter ST, et al. (2019) In Vitro Testing of a First-In-Class Tri-alkylnorspermidine-biaryl Antibiotic in an Anti-biofilm Silicone Coating. Acta Biomaterialia |
| Williams DL, Epperson RT, Ashton NN, et al. (2019) In Vivo Analysis of a First-in-Class Tri-alkylnorspermidine-biaryl Antibiotic in an Active Release Coating to Reduce the Risk of Implant-Related Infection. Acta Biomaterialia |
| Spivak AM, Nell RA, Petersen M, et al. (2018) Synthetic Ingenols Maximize Protein Kinase C-Induced HIV-1 Latency Reversal. Antimicrobial Agents and Chemotherapy |
| Bharat D, Cavalcanti RRM, Petersen C, et al. (2017) Blueberry Metabolites Attenuate Lipotoxicity-Induced Endothelial Dysfunction. Molecular Nutrition & Food Research |